[pdf-embedder url=”/wp-content/uploads/2018/10/CAFC-and-PTAB-Update.pdf” title=”CAFC and PTAB Update”]
Author: sean
BPCIA Cases
[pdf-embedder url=”/wp-content/uploads/2018/10/BPCIA-Cases.pdf” title=”BPCIA Cases”]
Practical Consequences of SAS and Oil States
[pdf-embedder url=”/wp-content/uploads/2018/10/Practical-Consequences-of-SAS-and-Oil-States-FINAL.pdf” title=”Practical Consequences of SAS and Oil States FINAL”]
Patent Infringement Litigation In The US District Courts – Part 3
Step 8: Trial Trial: Mainly by Jury More than 95% of patent cases are tried by jury. The parties may waive the right to a jury trial and have the court try the case, but such waivers are rare. In jury trials, must propose jury instructions. Presentation of the evidence is…
Patent Infringement Litigation In The US District Courts – Part 2
Step 3: Fact Discovery (RFPs, ROGs, RFAs, Depos, Subpoenas) Scope of Discovery The US legal system allows for extensive pre-trial discovery. Generally, a party is entitled to any information relevant to a claim or defense in the lawsuit. Documents or information falling within certain privileges, such as the attorney-client privilege or…
Patent Infringement Litigation In The US District Courts – Part 1
Patent Infringement Litigation Overview Step 1: The Pleadings (Complaint, Answer, Reply) The Complaint: Pre Suit Investigation A patentee must form a reasonable basis for bringing an infringement action. Failure to do so can lead to sanctions, including expenses and attorney fees. Patentees should obtain a prelitigation opinion that analyzes…
Overview of US Law and Court System
Overview Of US Law –Federal and State Federal laws enacted by US Congress Patents are exclusively governed by federal law. The principal source of federal law governing patents is Title 35 of the US Code. Common law system relies on judicial precedent. Federal court decisions interpret the statutes and, in…
Recent Cases Affecting Pharma and Biologics
Recent Developments in Pharma and Biologics IP Law: A Discussion of Recent Cases Affecting Pharma and Biologics IP Law Topic 1: Cases Interpreting the Biologics Price Competition and Innovation Act (BPCIA) BPCIA – The Patent Dance Purple Book does not list patents. Instead, Biosimilars Act contemplates an initial exchange of…
general
Read more
Our compeling design 2
Non odit veritatis, debitis, minima nostrum nam iste. consectetur adipisicing elit. Ipsa quidem, iure placeat consequatur? Autem ut commodi facilis id, dolorum sit voluptate repudiandae non odit veritatis, debitis, minima nostrum nam iste.
general
Read more
Our compeling design
Non odit veritatis, debitis, minima nostrum nam iste. consectetur adipisicing elit. Ipsa quidem, iure placeat consequatur? Autem ut commodi facilis id, dolorum sit voluptate repudiandae non odit veritatis, debitis, minima nostrum nam iste.
